| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5104925 | Value in Health | 2016 | 7 Pages |
Abstract
The cost-effectiveness of ICS + LABA treatment is economically unfavorable in older adults when compared with LTRA as add-on treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Shoroq M. PharmD, PhD, Joshua M. PhD, MPH, Carolyn T. PhD, MPH, Kenneth J. MS, MD,